From: Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC
 | D | LT | HT | LP | HP | LA | HA |
---|---|---|---|---|---|---|---|
Acinar | 15(7.3%) | 6(2.9%) | 1(1%) | 5(2.4%) | 10(4.9%) | 0(0%) | 1(0.5%) |
Solid | 6(2.9%) | 8(3.9%) | 5(2.4%) | 4(1.9%) | 2(1%) | 0(0%) | 0(0%) |
Papillary | 6(2.9%) | 2(1%) | 2(1%) | 5(2.4%) | 5(2.4%) | 1(0.5%) | 1(0.5%) |
Micropapillary | 7(3.4%) | 0(0%) | 2(1%) | 0(0%) | 1(0.5%) | 0(0%) | 0(0%) |
Invasivemucinous | 2(1%) | 0(0%) | 0(0%) | 1(0.5%) | 0(0%) | 0(0%) | 0(0%) |
Lepidic | 0(0%) | 0(0%) | 0(0%) | 0(0%) | 1(0.5%) | 1(0.5%) | 0(0%) |